In an ongoing clinical trial of PRAXBIND, the blood-thinning effect of Pradaxa was fully reversed in 89 percent of patients within four hours of receiving PRAXBIND. PRAXBIND is given by intravenous injection. PRAXBIND is a drug to be used during emergency or life-threatening situations when there is a need to reverse the blood-thinning effects of Pradaxa, an anticoagulant, commonly called a “blood thinner”. Refer to the PRAXBIND Prescribing Information for complete information.ĭRUG TRIALS SNAPSHOT SUMMARY: What is the drug for? Always speak to your health provider about the risks and benefits of a drug. The Snapshot is intended as one tool for consumers to use when discussing the risks and benefits of the drugs.ĭo not rely on Snapshots to make decisions regarding medical care. The “MORE INFO” bar shows more detailed, technical content for each section. The information provided in Snapshots highlights who participated in the clinical trials that supported the FDA approval of this drug, and whether there were differences among sex, race and age groups.
0 Comments
Leave a Reply. |